Site 118 — Birmingham, Alabama

Public research footprint of Site 118, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Stopped or withdrawn

Most-studied conditions

Dry Eye Disease (DED) · Hypoactive Sexual Desire Disorder · Chronic Spontaneous Urticaria · Pemphigus Vulgaris

Recently updated registry entries

NCT05425940 — Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal… (Active Not Recruiting)
NCT06347133 — Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia (Active Not Recruiting)
NCT04516967 — Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Site 118?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.